- 9 November 2015
- book chapter
- Published by World Bank
- p. 69-84
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern AfricaInternational Journal of Cancer, 2011
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South AfricaVaccine, 2009
- Cost-Effectiveness Analysis of a Quadrivalent Human Papilloma Virus Vaccine in MexicoArchives of Medical Research, 2009
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Mathematical Models of Cervical Cancer Prevention in the Asia Pacific RegionVaccine, 2008
- Modeling Cervical Cancer Prevention in Developed CountriesVaccine, 2008
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesVaccine, 2008
- Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test ResultsJAMA, 2005